Skip to main content
Caplight Logo









BrilliantStrings Therapeutics, Inc.

BrilliantStrings Therapeutics, Inc.

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://brilliantstrings.com/

Last Round

Grant

Jun 23, 2025

Total Funding Raised

$2.95M

Company Overview

BrilliantStrings Therapeutics, Inc. is a biotechnology company that develops injectable collagen-based mechanotherapeutic platforms for the repair of injured or degenerated connective tissues.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicinebiomaterialsinjectable collagenmechanotherapeuticsconnective tissue repairorthopedic surgerytendon repairrotator cuff repairbiotechmedtechclinical trialstissue engineeringgood manufacturing practiceGMPcontract research organizationCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BrilliantStrings Therapeutics, Inc. Comparables

Compare BrilliantStrings Therapeutics, Inc. with similar companies based on industry and business-model similarity.

BrilliantStrings Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CollaMedix Inc.
76%
Miach Orthopaedics
75%
Zimmer Biomet
73%

BrilliantStrings Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 23, 2025
Series AMay 26, 2025

Key People

Founding team and executive leadership

Jeffrey Ruberti

Chief Executive Officer

Executive Team

Scott Weiss

Chief Operating Officer

Executive Team

BrilliantStrings Therapeutics, Inc. Investors

Notable investors and investment history

BrilliantStrings Therapeutics, Inc. investors
InvestorRounds
Northeastern University Center for Research InnovationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2025

    $200K grant received from LabCentral.

BrilliantStrings Therapeutics, Inc. Filings

Explore SEC and related filing metadata, where available.

BrilliantStrings Therapeutics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BrilliantStrings Therapeutics, Inc.'s valuation, stock price, and market status.

Is BrilliantStrings Therapeutics, Inc. a public or private company?

BrilliantStrings Therapeutics, Inc. is a private company.

What is the current stock price of BrilliantStrings Therapeutics, Inc.?

BrilliantStrings Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is BrilliantStrings Therapeutics, Inc. worth (valuation)?

Valuation information for BrilliantStrings Therapeutics, Inc. is not publicly available.

Can I buy BrilliantStrings Therapeutics, Inc. stock?

BrilliantStrings Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BrilliantStrings Therapeutics, Inc.'s last funding round?

Funding round information for BrilliantStrings Therapeutics, Inc. is not publicly available.

Who are the main investors in BrilliantStrings Therapeutics, Inc.?

Investor information for BrilliantStrings Therapeutics, Inc. is not publicly disclosed.

Will BrilliantStrings Therapeutics, Inc. IPO soon?

No public IPO plans have been announced for BrilliantStrings Therapeutics, Inc..

How can I track BrilliantStrings Therapeutics, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BrilliantStrings Therapeutics, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Year FoundedN/A
Last FundingJun 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?